Madison Park Capital Advisors’s Achieve Life Sciences ACHV Stock Holding History

Madison Park Capital Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,000	Closed	-$29.4K	–	66
2026 Q1	$29.4K	Hold	10,000	–	–	0.02%	62
2025 Q4	$49.7K	Hold	10,000	–	–	0.04%	61
2025 Q3	$31.5K	Hold	10,000	–	–	0.03%	62
2025 Q2	$22.6K	Hold	10,000	–	–	0.02%	61
2025 Q1	$26.7K	Hold	10,000	–	–	0.02%	58
2024 Q4	$35.2K	Hold	10,000	–	–	0.03%	59
2024 Q3	$47.4K	Hold	10,000	–	–	0.04%	73
2024 Q2	$47K	Hold	10,000	–	–	0.04%	70
2024 Q1	$45.5K	Hold	10,000	–	–	0.04%	69
2023 Q4	$41.2K	Buy	+10,000	New	+$43.6K	0.04%	61

Other funds holding ACHV

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Madison Park Capital Advisors's ACHV Position: Q2 2026 in Review

Madison Park Capital Advisors sold out of Achieve Life Sciences (ACHV) in Q2 2026, closing a stake of 10,000 shares — an estimated $29.4K sold.

Madison Park Capital Advisors first reported a position in ACHV in Q4 2023 and held it in 10 quarters. The position peaked at $49.7K in Q4 2025. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

Madison Park Capital Advisors reported no remaining Achieve Life Sciences position as of Q2 2026 after selling out during the quarter.
Madison Park Capital Advisors sold 10,000 Achieve Life Sciences shares in Q2 2026, an estimated $29.4K.
Madison Park Capital Advisors first reported a position in Achieve Life Sciences in Q4 2023 and held it in 10 quarters.
Madison Park Capital Advisors's Achieve Life Sciences position peaked at $49.7K in Q4 2025.
111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Madison Park Capital Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.